Home › Funds › TPG GP A, LLC › HALO
TPG GP A, LLC position in HALO
HALOZYME THERAPEUTICS INC · Health Care
TPG GP A, LLC reported holding 10,000,000 shares of HALO (HALOZYME THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$11.1M, representing 0.23% of its reported portfolio and ranking #42 among its reported holdings. TPG GP A, LLC has disclosed HALO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How TPG GP A, LLC's HALO position evolved
TPG GP A, LLC first disclosed a stake in HALO in Q1 2026 at 10,000,000 shares (US$10.4M). The position peaked in Q2 2026 at 10,000,000 shares, worth US$11.1M. Across 2 filings, TPG GP A, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 10,000,000 shares valued at US$11.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 10.00M | $10.37M | New |
| Q2 2026 | 10.00M | $11.11M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HALO and 13F data
HALO (HALOZYME THERAPEUTICS INC) is a Health Care company. 43 other funds we track also report a position in HALO — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$251.9M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$196.5M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HALO
- CONGRESS ASSET MANAGEMENT CO 2.28M sh · $251.89M · Q3 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.51M sh · $196.54M · Q2 2026
- SNYDER CAPITAL MANAGEMENT L P 2.40M sh · $187.54M · Q2 2026
- LOS ANGELES CAPITAL MANAGEMENT LLC 1.94M sh · $151.69M · Q2 2026
- WASATCH ADVISORS LP 1.05M sh · $115.88M · Q3 2026
- Stephens Investment Management Group LLC 1.39M sh · $109.02M · Q2 2026
- GW&K Investment Management, LLC 1.35M sh · $105.97M · Q2 2026
- Boston Trust Walden Corp 1.08M sh · $84.77M · Q2 2026
- LMR Partners LLP 45.00M sh · $65.81M · Q2 2026
- Mizuho Markets Cayman LP 834.50K sh · $65.32M · Q2 2026
More on TPG GP A, LLC
FAQ
How long has TPG GP A, LLC held HALO?
TPG GP A, LLC has disclosed HALO holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is TPG GP A, LLC's current position in HALO?
As of Q2 2026, TPG GP A, LLC holds 10.00M shares of HALO (HALOZYME THERAPEUTICS INC), valued at $11.11M, representing 0.23% of its reported portfolio and ranking #42.
Has TPG GP A, LLC been buying or selling HALO?
In the latest 13F filing (Q2 2026), TPG GP A, LLC held unchanged its position in HALO. The position peaked in Q2 2026 at 10.00M shares.
Which other funds hold HALO?
Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, SNYDER CAPITAL MANAGEMENT L P, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.